NK
NantKwest Inc
Halal Rating :
Last Price
$2.91
Last updated:
Market Cap
-
7D Change
17.34%
1 Year Change
-20.27%
Company Overview
Exchange
Next Earnings Date
ImmunityBio, Inc. (formerly NantKwest) is a clinical-stage immunotherapy company developing next-generation therapies that work with both the innate and adaptive immune system to treat cancer and infectious diseases. The company merged with NantKwest in March 2021 and focuses on developing novel cell and immunotherapy platforms.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $6.11m | $126.61m | - | $40.25m | 0.00% | 31.79% |
| June 30, 2024 | $1.05m | $139.4m | - | $39.02m | 0.00% | 27.99% |
| March 31, 2024 | $40000.0 | $132.72m | - | $37.49m | 0.00% | 28.24% |
Company Impact
Help us evaluate NantKwest Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.